TARSUS PHARMACEUTICALS, INC. Increase (Decrease) in Other Noncurrent Liabilities
TARSUS PHARMACEUTICALS, INC. (TARS) reported Increase (Decrease) in Other Noncurrent Liabilities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-02-23
- TARSUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was $0.00.
- TARSUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was $0.00.
- TARSUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-06-30 was $0.00.
- TARSUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-03-31 was $0.00.
- TARSUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2025 was $0.00.
- TARSUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2024 was -$233.00K, a 225.95% decline from fiscal 2023.
- TARSUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2023 was $185.00K.
- TARSUS PHARMACEUTICALS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$67.00K, a 158.26% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $0.00 derived: sum of 3 quarters · filed 2026-02-23 | $0.00 10-K · filed 2026-02-23 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | $0.00 derived: sum of 4 quarters · filed 2026-02-23 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-02-23 | $0.00 derived: sum of 4 quarters · filed 2026-02-23 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-01 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $0.00 derived: sum of 3 quarters · filed 2026-02-23 | -$1.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | -$1.00K derived: sum of 3 quarters · filed 2026-02-23 | -$233.00K 10-K · filed 2026-02-23 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$1.00K derived: sum of 2 quarters · filed 2025-11-04 | -$233.00K 10-Q · filed 2025-11-04 | -$44.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$233.00K 10-Q · filed 2025-08-06 | -$44.00K derived: sum of 3 quarters · filed 2026-02-23 | -$11.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | -$232.00K 10-Q · filed 2025-05-01 | -$43.00K derived: sum of 2 quarters · filed 2026-02-23 | -$10.00K derived: sum of 3 quarters · filed 2026-02-23 | -$39.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $222.00K derived: sum of 2 quarters · filed 2026-02-23 | $193.00K derived: sum of 3 quarters · filed 2026-02-23 | $185.00K 10-K · filed 2026-02-23 |
| 2023-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $4.00K derived: sum of 2 quarters · filed 2024-11-13 | -$4.00K 10-Q · filed 2024-11-13 | $3.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$37.00K 10-Q · filed 2024-08-08 | -$30.00K derived: sum of 3 quarters · filed 2025-02-25 | -$33.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$8.00K 10-Q · filed 2024-05-08 | -$1.00K derived: sum of 2 quarters · filed 2025-02-25 | -$4.00K derived: sum of 3 quarters · filed 2025-02-25 | -$32.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $4.00K derived: sum of 2 quarters · filed 2025-02-25 | -$24.00K derived: sum of 3 quarters · filed 2025-02-25 | -$67.00K 10-K · filed 2025-02-25 |
| 2022-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$31.00K derived: sum of 2 quarters · filed 2023-11-09 | -$74.00K 10-Q · filed 2023-11-09 | -$109.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$71.00K 10-Q · filed 2023-08-10 | -$106.00K derived: sum of 3 quarters · filed 2023-08-10 | -$63.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$43.00K 10-Q · filed 2023-05-09 | -$78.00K derived: sum of 2 quarters · filed 2023-05-09 | -$35.00K derived: sum of 3 quarters · filed 2023-05-09 | -$51.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $8.00K derived: sum of 2 quarters · filed 2023-03-17 | -$8.00K derived: sum of 3 quarters · filed 2023-03-17 | $115.00K 10-K · filed 2023-03-17 |
| 2021-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $27.00K derived: sum of 2 quarters · filed 2022-11-09 | $150.00K 10-Q · filed 2022-11-09 | $150.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $107.00K 10-Q · filed 2022-08-11 | $107.00K derived: sum of 3 quarters · filed 2022-08-11 | $107.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $123.00K 10-Q · filed 2022-05-11 | $123.00K derived: sum of 2 quarters · filed 2022-05-11 | $123.00K derived: sum of 3 quarters · filed 2022-05-11 | $123.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $0.00 derived: sum of 2 quarters · filed 2022-03-14 | $0.00 derived: sum of 3 quarters · filed 2022-03-14 | $0.00 10-K · filed 2022-03-14 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |